Watch: Priscilla Chan on CZI’s science milestones and what’s next

Watch CZI and CZ Biohub Chicago leadership reflect on new scientific achievements, including access to state-of-the-art AI-powered cell models and real-time inflammation biosensors.

, ,

As we welcome the new year, CZI Co-Founder and Co-CEO Priscilla Chan sat down with Patricia Brennan, vice president of science technology and general manager for science at CZI, and Shana Kelley, president of the Chan Zuckerberg Biohub Chicago, to reflect on the progress made over the past year in building tools to better understand and measure disease — and the exciting work still ahead.

From releasing a platform for researchers and biologists to easily access state-of-the-art AI-powered cell models to debuting the Chicago Biohub’s first-of-its-kind sensor to monitor inflammation in real-time, the conversation highlighted tangible work towards accelerating biomedical research and demonstrating progress toward CZI’s mission to cure, prevent or manage all diseases by the end of the century.

News

  • AP: Zuckerberg, Chan shift bulk of philanthropy to science, focusing on AI and biology to curb disease

  • Axios: Zuckerberg and Chan bet AI can cure all disease

  • Biohub launches first large-scale scientific initiative combining frontier AI with frontier biology to cure or prevent disease

    Biohub to unite data, compute, experimental science, and AI to transform and accelerate scientific research.